Stavros Vizirgianakis, CEO, Director at Misonix, holds 6.96M shares in Xtant Medical Holdings (Ticker: XTNT), holds 2.78M shares in Bioventus (Ticker: BVS), holds 1.65M shares in Misonix (Ticker: MSON).
What was Stavros Vizirgianakis’s latest transaction?
Stavros Vizirgianakis latest transaction was an Uninformative Buy of ―.
What was Stavros Vizirgianakis's most profitable transaction?
Stavros Vizirgianakis’s most profitable transaction was an Informative Buy of MSON stock on March 12, 2020. The return on the trade was 102.10%.
What is Stavros Vizirgianakis's role in Misonix?
Stavros Vizirgianakis's role in Misonix is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.